Medicare Enrolled
Dr. Abraham Kalikstein, M.D.
Neurology · New Hyde Park, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kalikstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalikstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kalikstein
Dr. Abraham Kalikstein is a neurology specialist in New Hyde Park, NY, with 11 years of NPI registration. Based on federal Medicare data, Dr. Kalikstein performed 2,731 Medicare services across 1,336 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kalikstein received a total of $13,580 from 53 pharmaceutical and/or device companies across 837 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kalikstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 16% volume in NY
$13,580 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,731
Medicare services
Top 16% in NY for neurology
1,336
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~248 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
929 | $1 | $8 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
234 | $54 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
227 | $72 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $103 | $137 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
139 | $90 | $575 |
| New patient office visit, complex (60-74 min) | 113 | $187 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
93 | $158 | $275 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
73 | $12 | $25 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
69 | $364 | $500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
60 | $144 | $200 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
58 | $144 | $400 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
56 | $195 | $350 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
55 | $204 | $500 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
55 | $155 | $375 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
54 | $211 | $400 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
42 | $191 | $720 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
38 | $103 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $78 | $125 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 28 | $249 | $350 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
22 | $100 | $600 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
22 | $10 | $93 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
21 | $122 | $182 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
21 | $229 | $780 |
| Emergency department visit, low level of medical decision making An emergency department visit for a patient requiring a low level of medical decision making. |
21 | $67 | $175 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
20 | $41 | $110 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $119 | $225 |
| Video EEG monitoring, 12-26 hours This procedure records brain wave activity using an electroencephalogram (EEG) while simultaneously capturing video footage for a duration of 12 to 26 hours. |
14 | $213 | $400 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
14 | $50 | $75 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $75 | $100 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
11 | $212 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,580
Total received (2020-2024)
Avg $2,716/year across 5 years
Top 22% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
837
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,580 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,094
2023
$3,508
2022
$2,594
2021
$2,786
2020
$598
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,106
PFIZER INC.
$489
Eisai Inc.
$333
Takeda Pharmaceuticals U.S.A., Inc.
$282
SK Life Science, Inc.
$267
Neurocrine Biosciences, Inc.
$259
ARGENX US, INC.
$230
UCB, Inc.
$218
Grifols USA, LLC
$179
Lundbeck LLC
$155
MITSUBISHI TANABE PHARMA AMERICA, INC.
$92
Neurelis, Inc.
$80
Octapharma USA, Inc.
$73
Alexion Pharmaceuticals, Inc.
$68
SCILEX PHARMACEUTICALS INC.
$56
AstraZeneca Pharmaceuticals LP
$42
Lilly USA, LLC
$40
Biogen, Inc.
$38
Microtransponder, Inc.
$29
Amneal Pharmaceuticals LLC
$24
Amgen Inc.
$19
Otsuka America Pharmaceutical, Inc.
$14
Top 3 companies account for 47.1% of 2024 payments
All-time payments by company (2020-2024) ›
ABBVIE INC.
$2,989
SK Life Science, Inc.
$1,059
Neurocrine Biosciences, Inc.
$752
PFIZER INC.
$653
Takeda Pharmaceuticals U.S.A., Inc.
$629
UCB, Inc.
$625
Eisai Inc.
$591
AbbVie Inc.
$585
ARGENX US, INC.
$463
Amgen Inc.
$453
Allergan, Inc.
$451
Alexion Pharmaceuticals, Inc.
$367
Grifols USA, LLC
$364
Lundbeck LLC
$354
Biohaven Pharmaceutical Holding Company Ltd.
$270
Biohaven Pharmaceuticals, Inc.
$256
ACADIA Pharmaceuticals Inc
$250
Biogen, Inc.
$242
Octapharma USA, Inc.
$218
MITSUBISHI TANABE PHARMA AMERICA, INC.
$204
Teva Pharmaceuticals USA, Inc.
$182
GENZYME CORPORATION
$152
Lilly USA, LLC
$108
UPSHER-SMITH LABORATORIES LLC
$99
IMPEL PHARMACEUTICALS INC.
$97
Mallinckrodt Hospital Products Inc.
$81
EMD Serono, Inc.
$81
Neurelis, Inc.
$80
Corium, LLC
$78
Otsuka America Pharmaceutical, Inc.
$70
AstraZeneca Pharmaceuticals LP
$70
Amneal Pharmaceuticals LLC
$69
SCILEX PHARMACEUTICALS INC.
$56
GE HealthCare
$55
Sumitomo Pharma America, Inc.
$49
CSL Behring
$46
Janssen Pharmaceuticals, Inc
$44
Zogenix Inc.
$38
Sunovion Pharmaceuticals Inc.
$38
Genentech USA, Inc.
$31
Adamas Pharmaceuticals, Inc.
$30
Microtransponder, Inc.
$29
Kyowa Kirin, Inc.
$27
Exeltis, USA Inc.
$24
Assertio Therapeutics, Inc.
$24
Abbott Laboratories
$23
CATALYST PHARMACEUTICALS, INC.
$21
Almatica Pharma LLC
$20
Avion Pharmaceuticals
$19
Scilex Pharmaceuticals Inc.
$19
EISAI INC.
$17
Catalyst Pharmaceuticals, Inc.
$16
GE HEALTHCARE
$13
Top 3 companies account for 35.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AJOVY · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · BOTOX · BRILINTA · Briviact · CAMBIA · COMIRNATY · Cenobamate · DUOPA · Dhivy · ELYXYB - CELECOXIB · EMGALITY · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD LIQUID · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · INFINITY · INGREZZA · KISUNLA · KYNMOBI · Kcentra · Leqembi · NAPRELAN · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · Soliris · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,181
Per 100K population
85.1
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kalikstein is a mixed practice specialist, with above-average Medicare volume (top 16% in NY), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kalikstein experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Kalikstein performed 929 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kalikstein receive payments from pharmaceutical companies?
Yes. Dr. Kalikstein received a total of $13,580 from 53 companies across 837 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalikstein's costs compare to other neurologists in New Hyde Park?
Dr. Kalikstein's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalikstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in New Hyde Park
Browse neurologists in New Hyde Park ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology